CCM
Cutter Capital Management Portfolio holdings
AUM
$230M
This Quarter Return
+2.37%
1 Year Return
+11.51%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$230M
AUM Growth
+$230M
(-5.9%)
Cap. Flow
-$16.9M
Cap. Flow
% of AUM
-7.37%
Top 10 Holdings %
Top 10 Hldgs %
62.84%
Holding
31
New
10
Increased
5
Reduced
6
Closed
10
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$18M |
| 2 |
Biogen
BIIB
|
$15.5M |
| 3 |
Eli Lilly
LLY
|
$14.9M |
| 4 |
Roivant Sciences
ROIV
|
$13.1M |
| 5 |
VRNA
Verona Pharma
VRNA
|
$10.2M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$22.4M |
| 2 |
Johnson & Johnson
JNJ
|
$20.5M |
| 3 |
AbbVie
ABBV
|
$18.1M |
| 4 |
Sarepta Therapeutics
SRPT
|
$15.1M |
| 5 |
Royalty Pharma
RPRX
|
$12.7M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Moderna
MRNA
$9.42B
| – | – |
-197,500
| Closed | -$8.21M |
|
27
Neumora Therapeutics
NMRA
$279M
| – | – |
-150,000
| Closed | -$1.59M |
|
|
28
Regeneron Pharmaceuticals
REGN
$60.8B
| – | – |
-31,500
| Closed | -$22.4M |
|
|
29
Sarepta Therapeutics
SRPT
$1.79B
| – | – |
-124,256
| Closed | -$15.1M |
|
30
Vera Therapeutics
VERA
$1.45B
| – | – |
-212,696
| Closed | -$8.99M |
|
31
Viridian Therapeutics
VRDN
$1.54B
| – | – |
-628,677
| Closed | -$12.1M |
|